Manage Or Innovate? One Man's Solutions To A Classic Quandary

First ‘superchemist’ Ed Engler threw corporate hierarchy to the winds, then IBM promoted him for it None of his IBM colleagues would have ever guessed that Edward Engler was about to turn his career upside-down on that February day in 1987. But looking back on it, the signs were there. Everyone knew this about Engler: The 39-year-old chemist was moving smartly along Big Blue’s management track. Already a second-tier manager, he had four laboratory directors reporting to hi

Written byPaul Raeburn
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

First ‘superchemist’ Ed Engler threw corporate hierarchy to the winds, then IBM promoted him for it

None of his IBM colleagues would have ever guessed that Edward Engler was about to turn his career upside-down on that February day in 1987. But looking back on it, the signs were there.

Everyone knew this about Engler: The 39-year-old chemist was moving smartly along Big Blue’s management track. Already a second-tier manager, he had four laboratory directors reporting to him and was well liked by both his bosses and the scientific staff.

Everyone also knew that there was something a bit different about Engler as a manager. Unlike many of his peers, as he stepped up the corporate ladder he had never quite lost his hankering for the bench. Every now and again, Engler would feel the old urge to tinker, and when it got the better of him, he would just ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies